EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic Approach Based on Nanotechnology with Chitosan-Coated Zein Nanoparticles Containing Quercetin Against Resistant Klebsiella pneumoniae Clinical Isolates

Azael Francisco Silva-Neto, Maria Anndressa Alves Agreles iD, Ana Alice Venancio Correia iD, Hanne Lazla Rafael de Queiroz Macêdo iD, Alane Rafaela de Carvalho Amaral, Alexsandra Maria Lima Scavuzzi, João Victor de Oliveira Alves, Ana Catarina Souza Lopes, Márcia Vanusa da Silva, Maria Tereza Dos Santos Correia, Isabella Macário Ferro Cavalcanti iD, Luís André de Almeida Campos

Pharmaceutics · 22.09.2025 · 17 (9) · 1227

DOI: 10.3390/pharmaceutics17091227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 22.09.2025. Verfasst von Azael Francisco Silva-Neto und 11 weiteren Autor:innen. Beteiligte Einrichtung: Keizo Asami Institute (iLIKA), Federal University of Pernambuco (UFPE), Recife 50670-901, PE, Brazil. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Productivity, the CNPq/MCTI/CT-Health Call 52/2022—Actions in Science, Technology, and Innovation to Address Antimicrobial Resistance (AMR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The study developed, characterized, and evaluated the toxicity, antibacterial and antibiofilm activity of quercetin encapsulated in chitosan-coated zein nanoparticles (QUER-ZNP-CH).

Methods

QUER-ZNP-CH were prepared by the nanoprecipitation method and characterized by physicochemical analyses, stability (12 months), and release kinetics. Toxicity was evaluated through hemocompatibility and a Tenebrio molitor larval model. Antibacterial activity (MIC/MBC, CLSI) and antibiofilm potential (crystal violet assay) were tested against resistant Klebsiella pneumoniae strains.

Results

The nanoparticles were prepared, and physicochemical analyses revealed chemical interactions, efficient encapsulation of the drug, and thermal stability. The formulations remained stable over 12 months, and the release kinetics demonstrated controlled release for 72 h. No hemotoxic profile was observed and there was 95% survival of Tenebrio molitor larvae after treatment with QUER-ZNP-CH. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of QUER-ZNP-CH revealed enhanced antibacterial activity of QUER, as indicated by a 32 to 64-fold reduction in the MIC and MBC values. The biofilm inhibition potential of QUER-ZNP-CH showed 60–100% inhibition and 25–95% eradication in concentrations from 0.12 to 62.5 μg/mL.

Conclusions

Thus, this nanotechnology-based formulation suggests potential for the treatment of bacterial infections caused by multidrug-resistant K. pneumoniae strains.

Schlagwörter

Stichwörter der Autor:innen

antibacterial therapybacterial resistancebiofilmsnanostructures

Autor:innen und Institutionen

  • Keizo Asami Institute (iLIKA), Federal University of Pernambuco (UFPE), Recife 50670-901, PE, Brazil.
  • Department of Pharmaceutical Sciences, Federal University of Pernambuco (UFPE), Recife 50670-901, PE, Brazil.
  • Laboratory of Microbiology, Department of Tropical Medicine, Federal University of Pernambuco, Recife 50670-901, PE, Brazil.
  • Department of Biochemistry, Federal University of Pernambuco, Recife 50670-901, PE, Brazil.
  • Laboratory of Microbiology & Immunology, Academic Center of Vitoria, Federal University of Pernambuco, Vitória de Santo Antão 55608-680, PE, Brazil.
  • Laboratory of Microbiology and Parasitology, Campus Ouricuri, University of Pernambuco, Ouricuri 56200-000, PE, Brazil.

ORCID-Profile: Maria Anndressa Alves Agreles, Ana Alice Venancio Correia, Hanne Lazla Rafael de Queiroz Macêdo, Isabella Macário Ferro Cavalcanti

Förderung

  • Research Productivity
  • the CNPq/MCTI/CT-Health Call 52/2022—Actions in Science, Technology, and Innovation to Address Antimicrobial Resistance (AMR)

Zitieren

APA

Silva-Neto, A. F., Agreles, M. A. A., Correia, A. A. V., Macêdo, H. L. R. Q., Amaral, A. R. C., Scavuzzi, A. M. L., Alves, J. V. O., Lopes, A. C. S., Silva, M. V. D., Correia, M. T. D. S., Cavalcanti, I. M. F., & Campos, L. A. A. (2025). Therapeutic Approach Based on Nanotechnology with Chitosan-Coated Zein Nanoparticles Containing Quercetin Against Resistant Klebsiella pneumoniae Clinical Isolates. Pharmaceutics, 17(9), 1227. https://doi.org/10.3390/pharmaceutics17091227

Vancouver

Silva-Neto AF, Agreles MAA, Correia AAV, Macêdo HLRQ, Amaral ARC, Scavuzzi AML, et al. Therapeutic Approach Based on Nanotechnology with Chitosan-Coated Zein Nanoparticles Containing Quercetin Against Resistant Klebsiella pneumoniae Clinical Isolates. Pharmaceutics. 2025;17(9):1227. doi:10.3390/pharmaceutics17091227

BibTeX
@article{SilvaNeto2025,
  author = {Silva-Neto, Azael Francisco and Agreles, Maria Anndressa Alves and Correia, Ana Alice Venancio and Macêdo, Hanne Lazla Rafael de Queiroz and Amaral, Alane Rafaela de Carvalho and Scavuzzi, Alexsandra Maria Lima and Alves, João Victor de Oliveira and Lopes, Ana Catarina Souza and Silva, Márcia Vanusa da and Correia, Maria Tereza Dos Santos and Cavalcanti, Isabella Macário Ferro and Campos, Luís André de Almeida},
  title = {Therapeutic Approach Based on Nanotechnology with Chitosan-Coated Zein Nanoparticles Containing Quercetin Against Resistant Klebsiella pneumoniae Clinical Isolates},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {9},
  pages = {1227},
  doi = {10.3390/pharmaceutics17091227}
}
Kostenlos starten →